News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 73–108
- Matches
- 213
- Sources here
- 18
- Companies here
- 9
Active search
213 matching headlines
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Medtronic gets CE mark for ablation to treat ventricular tachycardia
Medtronic has received an expanded CE mark for its Affera mapping and ablation system and Sphere-9 catheter to treat ventricular arrhythmias, including ventricular tachycardia. The Sphere-9 catheter also recently received breakthrough device designation from the FDA, acknowledging the need for more effective treatments for …
Palouse Capital Management Inc. Acquires 29,275 Shares of Medtronic PLC $MDT
Palouse Capital Management Inc. significantly increased its stake in Medtronic PLC (NYSE:MDT) during the second quarter, acquiring an additional 29,275 shares to bring its total holdings to 57,027 shares valued at approximately $4.46 million. This move comes as Medtronic exceeded analyst expectations with its …
180 Wealth Advisors LLC Lowers Holdings in Medtronic PLC $MDT
180 Wealth Advisors LLC significantly reduced its stake in Medtronic PLC (NYSE:MDT) by 75% in the second quarter, selling 29,822 shares and retaining 9,951 shares valued at $778,000. Despite this reduction, Medtronic reported strong quarterly results with revenue of $9.81 billion and adjusted EPS …
Balefire LLC Sells 25,744 Shares of Medtronic PLC $MDT
Balefire LLC significantly reduced its stake in Medtronic PLC (NYSE:MDT) by 67.1% in the second quarter, selling 25,744 shares but still retaining 12,614 shares valued at $987,000. Despite this institutional sell-off and recent price target reductions by analysts, Medtronic holds a "Moderate Buy" consensus …
Medtronic’s ablation system lands ventricular arrhythmia indication expansion in Europe
Medtronic's Sphere-9 catheter and Affera mapping and ablation system has secured a CE mark in Europe for ventricular arrhythmia treatment, making it the first all-in-one dual-energy catheter CE marked for this indication. The company is also pursuing US FDA clearance for the system for …
Medtronic Expands CE Mark Indication For Affera System For Ventricular Arrhythmias Treatment
(RTTNews) - Thursday, Medtronic plc (MDT) announced the expansion of the CE Mark indication for the Affera Mapping and Ablation System with Sphere-9 Catheter to treat ventricular arrhythmias, including ventricular tachycardia and premature ventricular complexes. The company stated that the expansion reflects its efforts …
Sharemaestro market context Price above Trend Line 52 weeks +15.8% · Next-week setup positive 57.9%Sphere-9 Maps and Ablates Ventricular Arrhythmias With Two Energies
Medtronic (NYSE: MDT) has announced an expanded CE Mark indication for its Affera™ Mapping and Ablation System with Sphere-9™ Catheter to treat ventricular arrhythmias, including ventricular tachycardia (VT) and premature ventricular complexes (PVCs). The Sphere-9 is the first all-in-one mapping and ablation, large-tip focal, …
Medtronic announces expanded CE Mark indication for Affera™ Mapping and Ablation System and Sphere-9™ Catheter for treatment of ventricular arrhythmias
Medtronic has received an expanded CE Mark indication for its Affera™ Mapping and Ablation System with Sphere-9™ Catheter to treat ventricular arrhythmias, including ventricular tachycardia (VT) and premature ventricular complexes (PVCs). This makes the Sphere-9 catheter the first all-in-one mapping and ablation, large-tip focal, …
Canandaigua National Bank & Trust Co. Takes $926,000 Position in Medtronic PLC $MDT
Canandaigua National Bank & Trust Co. has acquired a new stake of 11,842 shares in Medtronic PLC (NYSE:MDT) during the second quarter, valued at approximately $926,000. Medtronic exceeded quarterly expectations with $1.55 EPS and $9.81 billion in revenue, and raised its quarterly dividend to …
Medtronic on the future of AI-assisted surgery
Medtronic is advancing AI-assisted surgery with its new Touch Surgery Aide platform and the Hugo robotic surgery system. The platform, which has received FDA clearance for its first AI algorithm (Instrument Exit Point or IEP), aims to improve surgical safety, quality, and efficiency by …
I'm Calling It: Medtronic (MDT) Will Soar 40% by the End of 2026
Key Points Medtronic’s stock has slumped over the past five years. But its restructuring efforts could bring back the bulls.10 stocks we like better than Medtronic › Shares of Medtronic(NYSE: MDT), one of the world's largest medical device makers, have declined by more than …
Sharemaestro market context Price above Trend Line 52 weeks +15.8% · Next-week setup positive 57.9%Bronstein, Gewirtz & Grossman, LLC Encourages Sanara MedTech Inc. (SMTI) Shareholders to Inquire about Securities Investigation
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against Sanara MedTech Inc. (SMTI) on behalf of investors. This investigation follows a 24.7% stock price drop on November 12, 2026, after Sanara announced the discontinuation of its Tissue Health Plus program, incurring a $26.5 …
Medtronic (NYSE: MDT) grants 49,167 options and PSUs to EVP
Medtronic's EVP & President of Neuroscience, Thompson Kweli, received equity compensation including 17,306 performance share units, 49,167 stock options with a strike price of $86.68, and 6,923 restricted stock units. Additionally, 1,739 shares were withheld for tax purposes related to previously vested RSUs. The …
Medtronic plc (NYSE: MDT) grants PSUs, options and RSUs to HR chief
Medtronic plc's SVP, Chief HR Officer Walter Matthew R. received significant equity awards on August 3, 2026, including 5,769 restricted stock units, 14,421 performance share units, and stock options for 40,973 ordinary shares. The performance share units can yield between 0 and 34,610 shares …
Medtronic plc (NYSE: MDT) awards EVP Marinaro options, RSUs and PSUs
Medtronic plc's EVP Michael Marinaro received a significant equity award package, including restricted stock units (RSUs) with multi-year vesting, performance share units (PSUs) with a potential payout up to 65,760 shares, and stock options exercisable at $86.68 per share. Additionally, 3,356 ordinary shares were …
US jury says Medtronic owes $88 million in first case to go to trial over Covidien's hernia mesh
A federal jury in Boston has ordered Medtronic's Covidien unit to pay an Alabama man and his wife $88 million. This verdict marks the first trial out of thousands of lawsuits claiming injuries from Covidien's hernia-repair mesh implants. The jury found that Medtronic failed …
Sanara MedTech (NASDAQ:SMTI) Stock Rating Lowered by Freedom Capital
Freedom Capital downgraded Sanara MedTech (NASDAQ:SMTI) from "strong buy" to "hold," aligning with several other recent rating cuts for the company. The current analyst consensus is "Reduce," with a $35.00 price target, and SMTI is trading near its 52-week high at $34.00. Institutional investors, …
Do Wall Street Analysts Like Medtronic Stock?
Medtronic Plc HQ-by JHVEPhoto via iStock Galway, Ireland-based Medtronic plc (MDT) develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients. Valued at $109.3 billion by market cap, the company's principal products include those for bradycardia pacing, tachyarrhythmia management, atrial …
Sharemaestro market context Price above Trend Line 52 weeks +15.8% · Next-week setup positive 57.9%What Everyone Should Know About Brain Health and Stroke
Learn the warning signs of stroke and how new technologies are transforming neurovascular care. NORTHAMPTON, MA / ACCESS Newswire / August 4, 2026 / Medtronic - Your brain controls everything from how you move and speak to how you think, remember, and experience the …
Sharemaestro market context Price above Trend Line 52 weeks +15.8% · Next-week setup positive 57.9%Medtronic plc (MDT) Stock Analysis: Evaluating a 15% Upside Potential Amidst Robust Revenue Growth
Medtronic plc (MDT) shows a promising 15% upside potential, with analysts setting an average price target of $98.44. The company, a global leader in medical devices, boasts robust revenue growth of 9.90%, a healthy return on equity of 9.84%, and a substantial free cash …
Ainex's ENAD Chosen for Singapore's National University Hospital After Global Competition
ENAD, Korea's First and Only AI-Assisted Solution Approved for Both Upper and Lower GI Endoscopy ENAD Secures Singapore Hospital Adoption in Competition with Medtronic, Olympus, and Fujifilm Rapid Market Breakthrough Follows Singapore HSA Approval; Joint Research to Drive Further AI Performance Gains SEOUL, South …
Sharemaestro market context Price above Trend Line 52 weeks +15.8% · Next-week setup positive 57.9%Medtronic (MDT) Laps the Stock Market: Here's Why
Medtronic (MDT) closed at $86.68 in the latest trading session, marking a +1.51% move from the prior day. The stock outpaced the S&P 500's daily gain of 1.48%. Elsewhere, the Dow gained 1.32%, while the tech-heavy Nasdaq added 2.13%. The medical device company's shares …
Sharemaestro market context Price above Trend Line 52 weeks +15.8% · Next-week setup positive 57.9%Sanara MedTech Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Sanara MedTech Inc. - SMTI
Kahn Swick & Foti, LLC (KSF) is investigating the proposed sale of Sanara MedTech Inc. (SMTI) to MiMedx Group, Inc. (MDXG). KSF is examining whether the offered consideration of $33.00 in cash and 0.4735 shares of MiMedx common stock per Sanara share undervalues the …
Intuitive Surgical (ISRG) vs. Medtronic (MDT): Which MedTech Stock Looks Better Positioned for Growth?
Intuitive Surgical (NASDAQ:ISRG) beat both top- and bottom-line consensus estimates in its fiscal Q2 2026 results, with revenue for the quarter growing 19% to $2.89 billion and adjusted EPS reaching $2.80, exceeding expectations by $0.30. However, the stock declined as investors focused on concerns …
Sharemaestro market context Price above Trend Line 52 weeks +15.8% · Next-week setup positive 57.9%